Patents by Inventor Joanne L. Viney

Joanne L. Viney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IL-2 muteins and uses thereof
    Patent number: 11091526
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Grant
    Filed: November 25, 2019
    Date of Patent: August 17, 2021
    Assignee: PANDION OPERATIONS, INC.
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby
  • TARGETED IMMUNOTOLERANCE WITH A PD-1 AGONIST
    Publication number: 20210206856
    Abstract: Methods and polypeptides for conferring site-specific or local immune privilege.
    Type: Application
    Filed: August 19, 2020
    Publication date: July 8, 2021
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Kevin Lewis Otipoby, Salvatore Alioto, Lindsay J. Edwards, Jacob Glanville, David Maurer, Sarah Ives, Sawsan Youssef, Devanshi Shanghavi, Lauren Schwimmer
  • Targeted Immunotolerance
    Publication number: 20210094996
    Abstract: Methods and compounds for conferring site-specific or local immune privilege.
    Type: Application
    Filed: April 24, 2020
    Publication date: April 1, 2021
    Inventors: Joanne L. Viney, Nathan Higginson-Scott
  • Targeted immunotolerance
    Patent number: 10961310
    Abstract: Methods and compounds for conferring site-specific or local immune privilege.
    Type: Grant
    Filed: March 15, 2018
    Date of Patent: March 30, 2021
    Assignee: PANDION OPERATIONS, INC.
    Inventors: Joanne L. Viney, Nathan Higginson-Scott, Micah Benson, Alan Crane
  • IL-2 muteins and uses thereof
    Patent number: 10946068
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: March 16, 2021
    Assignee: PANDION OPERATIONS, INC.
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby
  • MAdCAM TARGETED IMMUNOTOLERANCE
    Publication number: 20200392228
    Abstract: Methods and compounds for conferring site-specific or local immune privilege, such as targeting to a cell expressing MAdCAM.
    Type: Application
    Filed: May 20, 2020
    Publication date: December 17, 2020
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Kevin Lewis Otipoby, Jyothsna Visweswaraiah, Salvatore Alioto, Lindsay J. Edwards, Erik Sampson, Jacob Glanville, David Maurer, Sarah Ives, Christina Pettus, Lauren Schwimmer
  • IL-2 MUTEINS AND USES THEREOF
    Publication number: 20200325202
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Application
    Filed: November 25, 2019
    Publication date: October 15, 2020
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby
  • IL-2 MUTEINS AND USES THEREOF
    Publication number: 20200325201
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Application
    Filed: November 25, 2019
    Publication date: October 15, 2020
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby
  • Targeted immunotolerance
    Patent number: 10676516
    Abstract: Methods and compounds for conferring site-specific or local immune privilege.
    Type: Grant
    Filed: May 24, 2018
    Date of Patent: June 9, 2020
    Assignee: PANDION THERAPEUTICS, INC.
    Inventors: Joanne L. Viney, Nathan Higginson-Scott
  • IL-2 MUTEINS AND USES THEREOF
    Publication number: 20190321446
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Application
    Filed: November 28, 2018
    Publication date: October 24, 2019
    Inventors: Nathan HIGGINSON-SCOTT, Joanne L. VINEY, Jyothsna VISWESWARAIAH, Erik Robert SAMPSON, Kevin Lewis OTIPOBY
  • BTNL9 proteins, nucleic acids, and antibodies and uses thereof
    Patent number: 10357561
    Abstract: The invention provides novel BTNL9 proteins, including multimers, fragments, and variants of a human BTNL9 protein. In addition, antibodies that can bind to BTNL9 proteins and nucleic acids encoding BTNL9 proteins are provided. Uses for BTNL9 proteins, and agonists or antagonists thereof, are described.
    Type: Grant
    Filed: May 5, 2015
    Date of Patent: July 23, 2019
    Inventors: Heather A. Arnett, Sabine S. Escobar, Ryan M. Swanson, Joanne L. Viney
  • IL-2 MUTEINS AND USES THEREOF
    Publication number: 20190169255
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Application
    Filed: December 21, 2018
    Publication date: June 6, 2019
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby
  • IL-2 MUTEINS AND USES THEREOF
    Publication number: 20190169254
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Application
    Filed: December 21, 2018
    Publication date: June 6, 2019
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby
  • IL-2 muteins
    Patent number: 10174091
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: January 8, 2019
    Assignee: Pandion Therapeutics, Inc.
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby
  • IL-2 muteins
    Patent number: 10174092
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: January 8, 2019
    Assignee: Pandion Therapeutics, Inc.
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby
  • Targeted Immunotolerance
    Publication number: 20180340014
    Abstract: Methods and compounds for conferring site-specific or local immune privilege.
    Type: Application
    Filed: May 24, 2018
    Publication date: November 29, 2018
    Inventors: Joanne L. Viney, Nathan Higginson-Scott
  • Targeted Immunotolerance
    Publication number: 20180265584
    Abstract: Methods and compounds for conferring site-specific or local immune privilege.
    Type: Application
    Filed: March 15, 2018
    Publication date: September 20, 2018
    Inventors: Joanne L. Viney, Nathan Higginson-Scott, Micah Benson, Alan Crane
  • BTNL9 Proteins, Nucleic Acids, and Antibodies and Uses Thereof
    Publication number: 20150344554
    Abstract: The invention provides novel BTNL9 proteins, including multimers, fragments, and variants of a human BTNL9 protein. In addition, antibodies that can bind to BTNL9 proteins and nucleic acids encoding BTNL9 proteins are provided. Uses for BTNL9 proteins, and agonists or antagonists thereof, are described.
    Type: Application
    Filed: May 5, 2015
    Publication date: December 3, 2015
    Inventors: Heather A. ARNETT, Sabine S. ESCOBAR, Ryan M. SWANSON, Joanne L. VINEY
  • Methods of using BTL-II proteins
    Patent number: 8674078
    Abstract: The invention provides isolated BTL-II proteins, nucleic acids, antibodies, antagonists, and agonists and methods of making and using the same. Diagnostic, screening, and therapeutic methods using the compositions of the invention are provided. For example, the compositions of the invention can be used for diagnosis and treatment of inflammatory bowel diseases and for enhancing a mucosal immune response to an antigen.
    Type: Grant
    Filed: April 10, 2012
    Date of Patent: March 18, 2014
    Assignee: Immunex Corporation
    Inventors: Peter R. Baum, Sabine S. Escobar, Joanne L. Viney
  • Calcimimetic compound for use in the treatment of epithelial injury
    Patent number: 8609655
    Abstract: This invention relates generally to the field of medicine and, more specifically, to methods for treating epithelial injury, in particular, due to ischemia, hypoxia, trauma, chemolytics or radiation exposure.
    Type: Grant
    Filed: March 27, 2009
    Date of Patent: December 17, 2013
    Assignee: Amgen Inc.
    Inventors: John Peter Geibel, David Martin, Gordon Ng, William G. Richards, Joanne L. Viney, Patricia R. Hebert